Correspondence 0001213900-24-074347 from Virpax Pharmaceuticals, Inc. (VRPX) (CIK 0001708331)
Virpax Pharmaceuticals, Inc. (VRPX) (CIK 0001708331)
Date: Aug. 30, 2024 · CIK: 0001708331 · Accession: 0001213900-24-074347
AI Filing Summary & Sentiment
File numbers found in text: 333-281080
Letter
Re: Virpax Pharmaceuticals, Inc.
August 30, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Registration Statement on Form S-1, as amended
File No. 333-281080
WITHDRAWAL OF ACCELERATION REQUEST
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on August 26, 2024, in which we, as the placement agent of the proposed public offering on a best efforts basis of securities of Virpax Pharmaceuticals, Inc. (the “Company”), joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for Monday, August 26, 2024, at 5:00 p.m. Eastern Time. The Company is no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
RBW Capital Partners LLC
Show Raw Text
CORRESP
1
filename1.htm
August 30, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: Virpax Pharmaceuticals, Inc.
Registration Statement on Form S-1, as amended
File No. 333-281080
WITHDRAWAL OF ACCELERATION REQUEST
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence
via EDGAR on August 26, 2024, in which we, as the placement agent of the proposed public offering on a best efforts basis of securities
of Virpax Pharmaceuticals, Inc. (the “Company”), joined the Company’s request for acceleration of the effective date
of the above-referenced Registration Statement for Monday, August 26, 2024, at 5:00 p.m. Eastern Time. The Company is no longer requesting
that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request for acceleration of the
effective date.
Very truly yours,
RBW Capital Partners LLC
By:
/s/ Philip Gaucher
Name:
Philip Gaucher
Title:
Managing Partner
Dominari Securities LLC
By:
/s/ Cosme Ordonez
Name:
Cosme Ordonez
Title:
Managing Director, Head of Investment Banking